Sarepta Therapeutics Inc

NASDAQ: SRPT
$109.96
-$0.91 (-0.8%)
Real Time Data Delayed 15 Min.

SRPT Stock Chart and Intraday Price

SRPT Stock Data

Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address 215 FIRST STREET, SUITE 415, CAMBRIDGE, MA, US
Fiscal Year End December
Latest Quarter 12/31/2023
Market Cap 12,036.65M USD
Shares Outstanding 93,547,000
Sarepta Therapeutics Inc is a pioneering biopharmaceutical company dedicated to developing unique treatments for rare diseases, with a strong focus on RNA-targeted therapies, gene therapies, and genetic therapeutic modalities. It is known for producing EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, targeting duchenne muscular dystrophy among other conditions. The company is actively working on advancing its pipeline, including SRP-5051 and SRP-9003 for muscular dystrophies. Founded in 1980 and based in Cambridge, Massachusetts, Sarepta collaborates with leading institutions to push the boundaries of genetic medicine.

SRPT Articles

NFL Team Owner Boosts a Stake, and Other Notable Insider Buying
An NFL team owner continues to boost a stake in an energy stock. Insiders made notable purchases in tech and health care stocks last week as well.
Trey Thoelcke
Published:

Prediction: This Pharma Stock Will Be the Best Performer the Rest of 2024
Market pullbacks can make nervous investors leery of investing in industries that are more speculative. Wall Street still has big expectations for Vir Biotechnology.
Trey Thoelcke
Published:

Huge Insider Buys at Energy Giants, Bill Ackman Boosts Real Estate Stake Again
Exxon Mobil and another energy giant saw huge insider buys this week, while Bill Ackman continued to build his stake in Howard Hughes.
Trey Thoelcke
Published:

Monday's Top Analyst Upgrades and Downgrades: Accenture, Moderna, Tesla, Under Armour, Wayfair, Welltower and More
Monday's top analyst upgrades and downgrades included Academy Sports and Outdoors, Accenture, Clorox, Fiserv, Moderna, Planet Fitness, Sarepta Therapeutics, Tesla, Under Armour, Ventas, Viatris,...
Lee Jackson
Published:

Tuesday's Top Analyst Upgrades and Downgrades: Caterpillar, CVS Health, Marvell Technology, Paramount, RingCentral, SoFi, UnitedHealth, Workday and More
Tuesday's top analyst upgrades and downgrades included Broadcom, Caterpillar, CVS Health, Guardant Health, Marvell Technology, Nutrien, Paramount Global, RingCentral, SoFi Technologies, UnitedHealth...
Lee Jackson
Published:

Thursday's Top Analyst Upgrades and Downgrades: Albertsons, Alphabet, Apple, Coinbase, General Electric, McDonald's, Microsoft, Tesla and More
Thursday's top analyst upgrades and downgrades included Albertsons Companies, Alphabet, Apple, Coinbase Global, Danaher, Enphase Energy, GE HealthCare Technologies, General Electric, McDonald's,...
Lee Jackson
Published:

Wednesday's Top Analyst Upgrades and Downgrades: American Express, Analog Devices, Boeing, Chevron, Comcast, CSX, Etsy, Prudential Financial and More
Wednesday's top analyst upgrades and downgrades included American Express, Analog Devices, Boeing, Chevron, Chipotle Mexican Grill, Comcast, CSX, Etsy, Fastenal, ONEOK, Prudential Financial, RH and...
Lee Jackson
Published:

Monday's Top Analyst Upgrades and Downgrades: Alphabet, Dollar General, FedEx, Microsoft, Nike, Nvidia, Shopify, Synchrony, Warner Bros Discovery and More
Monday's top analyst upgrades and downgrades included Alphabet, Bill, Bumble, Dollar General, FedEx, FMC, Jabil Circuit, Microsoft, Nike, Nvidia, Sarepta Therapeutics, Shopify, Synchrony Financial,...
Lee Jackson
Published:

Friday's Top Analyst Upgrades and Downgrades: AMD, Etsy, Meta Platforms, Salesforce, Sysco, Teladoc Health and More
Friday's top analyst upgrades and downgrades included Advanced Micro Devices, Asana, Etsy, Exact Sciences, Guardant Health, Hilton Worldwide, Meta Platforms, MongoDB, Salesforce, ServiceNow, Sysco...
Lee Jackson
Published:

Thursday's Top Analyst Upgrades and Downgrades: AbbVie, Boeing, Coupang, First Solar, Goldman Sachs, Johnson & Johnson, Monster Beverage, Rivian, Workday and More
Thursday's top analyst upgrades and downgrades included AbbVie, AutoZone, Boeing, Coupang, First Solar, Fortinet, Goldman Sachs, Johnson & Johnson, Marqeta, Monster Beverage, Rivian Automotive,...
Lee Jackson
Published:

Will Markets Turn Even Lower? Analysts Upgrade or Downgrade American Airlines, Meta Platforms and More
Friday’s additional top analyst upgrades and downgrades were on Alaska Air, American Airlines, Meta Platforms, New York Times, Southwest Airlines, United Airlines and more.
Chris Lange
Published:

Monday's Top Analyst Upgrades and Downgrades: Activision Blizzard, Amazon, Deere, DraftKings, Meta Platforms, Redfin, Tyson Foods, Visa, Wynn Resorts and More
Monday's top analyst calls were on Activision Blizzard, Amazon.com, Bilibili, Coupa Software, Deere, DraftKings, JD.com, Lufax, Meta Platforms, Redfin, Tyson Foods, Visa, Upstart, Wynn Resorts and...
Lee Jackson
Published:

Barclays Has 3 Big Names With Massive Upside
Barclays recently issued a few calls across multiple industries implying serious upside for each stock, but one in particular with over 30% upside.
Chris Lange
Published:

Tuesday's Top Analyst Upgrades and Downgrades: Analog Devices, Caesars, Chevron, Hertz, Li Auto, Starbucks, Tesla, Twitter and More
Tuesday's top analyst upgrades and downgrades included Analog Devices, Baxter, BorgWarner, Caesars Entertainment, CarMax, Chevron, Hertz Global, Li Auto, Starbucks, Tesla and Twitter.
Lee Jackson
Published:

Tuesday's 10 Premarket Winners and Losers Include Cheniere Energy, CF Industries and Stryker
Here are Tuesday's leaders and laggards in the premarket session. Energy stocks were the day's big winners early on.
Paul Ausick
Published: